ACC is dedicated to creating a strong, diverse and inclusive field of future cardiovascular physicians and scientists. ACC's Internal Medicine Cardiology Programs are designed to introduce ...
ACC Past President Geller Professor of Research in CV Disease ...
Cardiovascular disease (CVD) is the leading cause of pregnancy-related maternal death in the United States, driven by rising rates of hypertension, diabetes mellitus (DM), obesity, smoking, and ...
The following are key points to remember from a review on national- and state-level prevalence of overweight and obesity among children, adolescents, and adults in the United States (US), 1990–2021, ...
Nonbacterial thrombotic endocarditis (NBTE), previously known as marantic endocarditis, is a rare condition characterized by the formation of sterile vegetations on the surface of heart valves.
Both current-generation balloon-expandable valves (BEVs) and self-expanding valves (SEVs) are effective for bicuspid aortic valve stenosis, showing a comparably high rate of technical success and ...
Outpatient initiation of sotalol with use of a personal remote ECG device and pharmacist-led dose adjustments is safe and feasible in carefully selected patients. Compared to inpatient loading ...
Fill out a brief survey created by the chairs of ACC's International FIT and Early Career Cardiologists focusing on burnout, health and wellness. The survey should take you approximately five minutes ...
An expert panel report, one of three in a special series published in JACC: CardioOncology, provides a review of the current evidence for the cardiovascular care of patients before cardiotoxic cancer ...
Preventing, detecting and managing cancer therapy-related cardiovascular toxicity (CTR-CVT) is a clear objective during cancer treatment. An expert panel report published in JACC: CardioOncology ...
The following are key points to remember from an international consensus on cardiopulmonary resuscitation (CPR) and emergency cardiovascular care science with treatment recommendations: ...
New science presented at AHA 2024 and simultaneously published in JACC: Advances provide insights on emerging topics such as the use of artificial intelligence (AI)-enabled left atrial (LA) volumetry ...